SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021529
Filing Date
2022-11-03
Accepted
2022-11-03 07:05:08
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agle-20220930.htm   iXBRL 10-Q 3447443
2 EX-31.1 agle-ex31_1.htm EX-31.1 18431
3 EX-31.2 agle-ex31_2.htm EX-31.2 18436
4 EX-32.1 agle-ex32_1.htm EX-32.1 10510
5 EX-32.2 agle-ex32_2.htm EX-32.2 10504
6 GRAPHIC img116064786_0.jpg GRAPHIC 61045
  Complete submission text file 0000950170-22-021529.txt   9557365

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agle-20220930_pre.xml EX-101.PRE 239287
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agle-20220930_cal.xml EX-101.CAL 43846
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agle-20220930_lab.xml EX-101.LAB 336357
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agle-20220930_def.xml EX-101.DEF 129979
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agle-20220930.xsd EX-101.SCH 37804
49 EXTRACTED XBRL INSTANCE DOCUMENT agle-20220930_htm.xml XML 1866081
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 221356147
SIC: 2834 Pharmaceutical Preparations